An Open-Label Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of OV101 in Individuals With Angelman Syndrome
Clinical trial NCT03882918 · TERMINATED
Trial details
- NCT number
- NCT03882918
- Sponsor
- Healx AI
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-31
- Primary completion
- 2021-06-04
- Enrollment
- 141
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.